Van ECK Associates Corp Decreases Holdings in Chemed Corporation $CHE

Van ECK Associates Corp lessened its stake in shares of Chemed Corporation (NYSE:CHE) by 9.2% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,437 shares of the company’s stock after selling 1,364 shares during the period. Van ECK Associates Corp owned about 0.10% of Chemed worth $6,258,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Monetary Solutions Ltd bought a new stake in Chemed in the 4th quarter valued at about $25,000. Los Angeles Capital Management LLC bought a new position in Chemed in the 4th quarter valued at $26,000. BOK Financial Private Wealth Inc. bought a new stake in Chemed during the fourth quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Chemed during the 2nd quarter valued at about $34,000. Finally, Versant Capital Management Inc grew its stake in Chemed by 7,500.0% in the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after buying an additional 75 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total value of $1,079,020.00. Following the transaction, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at approximately $37,991,215.18. This trade represents a 2.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Spencer S. Lee sold 1,000 shares of Chemed stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $541.04, for a total value of $541,040.00. Following the transaction, the executive vice president directly owned 13,912 shares in the company, valued at approximately $7,526,948.48. The trade was a 6.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 6,537 shares of company stock worth $3,406,014 over the last quarter. Company insiders own 3.33% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on CHE shares. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Bank of America reiterated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Royal Bank Of Canada boosted their price target on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Finally, Oppenheimer upped their price target on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Chemed presently has an average rating of “Hold” and an average target price of $530.75.

Chemed Stock Up 2.0%

Chemed stock opened at $525.49 on Thursday. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $557.00. The stock has a fifty day simple moving average of $514.08 and a two-hundred day simple moving average of $450.97. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. The firm has a market cap of $6.87 billion, a price-to-earnings ratio of 26.39, a PEG ratio of 1.95 and a beta of 0.51.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. The business had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities analysts predict that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. Chemed’s dividend payout ratio (DPR) is currently 14.06%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.